Evoke Pharma, Inc. (EVOK)

Market Cap	7.26M
Revenue (ttm)	8.62M
Net Income (ttm)	-6.15M
Shares Out	1.59M
EPS (ttm)	-6.87
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	10,437
Open	4.700
Previous Close	4.700
Day's Range	4.510 - 4.700
52-Week Range	3.540 - 17.400
Beta	0.35
Analysts	n/a
Price Target	n/a
Earnings Date	Nov 7, 2024

About EVOK

Evoke Pharma, Inc., a specialty pharmaceutical company, primarily focuses on the development and commercialization of drugs for the treatment of gastroenterological disorders and diseases. It offers Gimoti, a metoclopramide nasal spray to treat symptoms associated with acute and recurrent diabetic gastroparesis in adults. The company markets its products to gastroenterologists, internal medicine specialists, primary care physicians, and select health care providers. Evoke Pharma, Inc. was incorporated in 2007 and is headquartered in Solana Beac...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• IPO Date: Sep 25, 2013
• Employees: 4
• Stock Exchange: NASDAQ
• Ticker Symbol: EVOK
• Website: https://www.evokepharma.com

Financial Performance

In 2023, Evoke Pharma's revenue was $5.18 million, an increase of 106.51% compared to the previous year's $2.51 million. Losses were -$7.79 million, -5.25% less than in 2022.